Efficacy of T-cell transcription factor–specific DNAzymes in murine skin inflammation models - 05/02/16
The research reported in this article was supported by the German Federal Ministry of Education and Research, Bonn, Germany (grant no. 031A188); the German Federal Ministry of Economic Affairs and Energy, Bonn, Germany (grant no. KF2614701FR0); the HA Hessen Agentur, Wiesbaden, Germany; and Sterna Biologicals GmbH & Co. KG, Marburg, Germany. The content is solely the responsibility of the authors. |
|
Disclosure of potential conflict of interest: U. Purath and A. Müller have received grants from the German Federal Ministry of Education and Research (grant no. 031A188), the German Federal Ministry of Economic Affairs and Energy (grant no. KF2614701FR0), and Hessen Agentur LOEWE-3 (grant nos. 137/07-01 and 205/09-35). R. Ibrahim has received travel support from Sterna Biologicals. J. Zeitvogel and T. Werfel have received grants from the German Federal Ministry of Economic Affairs and Energy (grant no. KF2117403FRO) and Sterna Biologicals. F. Runkel has received grants from Hessen Agentur LOEWE-3 (grant nos. 137/07-01 and 205/09-35) and Sterna Biologicals and has consultant arrangements with Engelhard Arzneimittel. T. Schmidts and D. Dobler have received grants from Hessen Agentur LOEWE-3 (grant nos. 137/07-01 and 205/09-35). H. Renz and H. Garn hold shares of and have received a consulting fee or honorarium from Sterna Biologicals. |
Vol 137 - N° 2
P. 644 - février 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?